Hansa Biopharma appoints Hitto Kaufmann as chief scientific officer

Hansa Biopharma (HNSA) announced that Hitto Kaufmann has been appointed as Hansa’s chief scientific officer, or CSO, effective December 1. As CSO, Kaufmann will be responsible for all research, early development, translational and manufacturing activities. He will report to president and CEO Soren Tulstrup and serve as a member of Hansa’s executive committee. Kaufmann joins Hansa from Pieris Pharmaceuticals (PIRS) where he has served as chief scientific officer since 2019.